Review
Biological functions of Elabela, a novel endogenous ligand of APJ receptor.
J. Cell. Physiol. 2018 Sep 1; 233 (9): 6472-6482.
Article
ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
Cardiovasc. Res. 2017 Jun 1; 113 (7): 760-769.
Review
Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.
Trends Pharmacol. Sci. 2015 Sep 1; 36 (9): 560-7.